Latest Capital Raising News

Skylark Minerals Limited reported a $706,000 operating cash outflow and a $6.4 million investment in exploration during the December 2025 quarter, ending with $2.9 million in cash. The company’s financing activities provided a $3.3 million inflow, supporting its ongoing operations.

6K Additive reported a strong finish to 2025 with a 25% revenue jump in Q4 and secured $31.4 million in IPO proceeds to fuel a fivefold production expansion. The company also landed a $27.4 million US government-backed loan, positioning it for accelerated growth in the additive manufacturing sector.

Sunrise Energy Metals advances its Syerston Scandium Project with a robust updated Ore Reserve supporting a 32-year mine life, alongside significant financing commitments and a strategic offtake option with Lockheed Martin.

Galan Lithium has raised A$40 million through an institutional placement to expand production at its Hombre Muerto West project by 30%, aiming for first lithium output in the first half of 2026.

Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.

Bannerman Energy reported a strong cash position of AUD 89.3 million at the end of December 2025, supported by significant equity financing and ongoing exploration investments. The company’s funding runway now extends to over nine quarters, providing a solid buffer for its uranium exploration activities.

Australian Critical Minerals has raised $3 million through a heavily oversubscribed placement to fund maiden drilling at its promising Flint Gold-Silver Project in Peru.

Broken Hill Mines has delivered a standout December quarter with record mining rates at Rasp Mine, strong exploration results, and a robust financial position, setting the stage for accelerated growth in 2026.

Critical Resources Limited has secured a $1.75 million placement at market price, reinforcing investor confidence as it advances lithium, gold-antimony, and solid-state battery initiatives.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

Arafura Rare Earths has raised A$481 million in equity funding and secured key government backing, advancing its Nolans Project towards a final investment decision in 2026.

Diablo Resources reports significant exploration advances at its Star Range silver-antimony and Phoenix copper projects in Utah, backed by a $2 million capital raise and new OTCQB listing to boost U.S. investor access.